π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Cholangiocarcinoma (CCA) is a heterogeneous group of cancers arising from t...
Status
Recruiting
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2023-09-01
Trial ID
NCT05823311
Treatments Being Tested
This is a multicenter, open-label, prospective, single-arm, phase II study ...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2025-10-25
Trial ID
NCT07296705
Treatments Being Tested
This study is designed prospectively to investigate the safety and efficacy...
Status
Unknown
Location
Shanghai Renji Hospital
Start Date
2020-12-10
Trial ID
NCT04672317
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of tisleliz...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-12-14
Trial ID
NCT04486391
Treatments Being Tested
To investigate the efficacy and tolerability of neoadjuvant tislelizumab, g...
Status
Not Yet Recruiting
Location
National Cheng Kung University Hospital
Start Date
2025-07-01
Trial ID
NCT06903273
Treatments Being Tested
This trial investigates the efficacy and safety of the drug tislelizumab in...
Status
Active Not Recruiting
Location
BE-Bruxelles-STLUC
Start Date
2023-07-14
Trial ID
NCT05502250
Treatments Being Tested
The study is being conducted to evaluate the safety and efficacy of tisleli...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-12-01
Trial ID
NCT06177301
Treatments Being Tested
This is a prospective, multicenter, Phase Ib clinical study designed to eva...
Status
Enrolling By Invitation
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2026-01-01
Trial ID
NCT07353294
Treatments Being Tested
This is a multicenter Phase 1b/2 clinical trial investigating the efficacy ...
Status
Recruiting
Location
CHA Bundang Medical Center
Start Date
2024-10-01
Trial ID
NCT06893380
Treatments Being Tested
The aim of this study is to see whether the Trilaciclib is safe and effecti...
Status
Not Yet Recruiting
Location
Nanfang Hospital, Southern Medical University
Start Date
2025-10
Trial ID
NCT06364904
Treatments Being Tested